Monday, August 24, 2020 9:33:09 PM
Riley,
I'd love to mod the board but I've got my hands full for the remainder of the year. Also, I'm probably on the "bad boy" list also...not too far from your name.
I haven't bought into LNTH yet. I've got an order in that hasn't triggered yet if it dips for some reason. Going to use a little TA and a gut feeling on entry price.
I'd love to mod the board but I've got my hands full for the remainder of the year. Also, I'm probably on the "bad boy" list also...not too far from your name.
I haven't bought into LNTH yet. I've got an order in that hasn't triggered yet if it dips for some reason. Going to use a little TA and a gut feeling on entry price.
Recent LNTH News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/20/2026 08:19:25 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:16:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/20/2026 08:13:32 PM
- Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) • GlobeNewswire Inc. • 03/17/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:06:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:05:00 PM
- Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection • GlobeNewswire Inc. • 03/06/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:19:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:19:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:19:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:18:58 PM
- Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® • GlobeNewswire Inc. • 03/02/2026 01:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:38:33 PM
- Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/26/2026 12:00:00 PM
- Lantheus to Present at March 2026 Investor Conferences • GlobeNewswire Inc. • 02/24/2026 01:30:00 PM
- Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time • GlobeNewswire Inc. • 02/12/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2026 06:32:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2026 04:43:40 PM
- Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies • GlobeNewswire Inc. • 01/02/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 09:15:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 08:16:49 PM

